Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CRM vs GSK✓SelectedUSD · GSKCRM vs GSK performance historyLatest closeAs of-1.47%11/20
Stock and ETF performance explorer

CRM vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+4,180.7%
GSK return
+224.8%
Excess return
+3,955.9%
Maximum drawdown
-70.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.5%-0.1%-1.3%-1.4%
7D-17.1%-5.3%-11.8%-14.9%
30D-25.3%-3.7%-21.6%-24.0%
3M-11.9%-7.3%-4.7%-9.1%
6M+0.7%-4.2%+5.0%+1.8%
YTD-31.4%+0.9%-32.2%-33.4%
1Y-19.2%+7.3%-26.5%-24.1%
3Y-18.2%+52.7%-71.0%-39.2%
5Y-38.9%+40.1%-79.0%-53.7%
10Y+136.7%+98.7%+38.0%+39.9%
All+4,180.7%+224.8%+3,955.9%+1,703.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling